Coreline N. Burggraaff
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.
Journal: Nature communications
Published: July 22, 2024
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 09, 2022
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 04, 2021
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 21, 2021
18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 27, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.
Journal: Blood advances
Published: February 08, 2021
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 15, 2020
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2020
Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma.
Journal: Molecular imaging and biology
Published: January 30, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Journal: Haematologica
Published: December 19, 2019
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 30, 2019
Last Updated: 09/26/2026